These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6778070)

  • 1. Group B meningococcal opsonins in serum measured by polymorphonuclear leukocyte chemiluminescence.
    Lehmann V; Solberg CO
    Acta Pathol Microbiol Scand C; 1980 Aug; 88(4):227-31. PubMed ID: 6778070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of a chemiluminescence method for the measurement of meningococcal opsonins using ethanol fixed meningococci.
    Halstensen A; Haneberg B
    Acta Pathol Microbiol Immunol Scand C; 1987 Aug; 95(4):155-60. PubMed ID: 3118640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum opsonins to serogroup B meningococci in meningococcal disease.
    Halstensen A; Sjursen H; Vollset SE; Frøholm LO; Naess A; Matre R; Solberg CO
    Scand J Infect Dis; 1989; 21(3):267-76. PubMed ID: 2502834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric assay for the measurement of serum opsonins to Neisseria meningitidis serogroup B, serotype 15.
    Sjursen H; Bjerknes R; Halstensen A; Naess A; Sørnes S; Solberg CO
    J Immunol Methods; 1989 Jan; 116(2):235-43. PubMed ID: 2492053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB.
    Lehmann AK; Halstensen A; Aaberge IS; Holst J; Michaelsen TE; Sornes S; Wetzler LM; Guttormsen H
    Infect Immun; 1999 May; 67(5):2552-60. PubMed ID: 10225920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization against serogroup B meningococci. Opsonin response in vaccinees as measured by chemiluminescence.
    Lehmann AK; Halstensen A; Naess A; Vollset SE; Sjursen H; Bjune G
    APMIS; 1991 Aug; 99(8):769-72. PubMed ID: 1907153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human opsonins to meningococci after vaccination.
    Halstensen A; Haneberg B; Frøholm LO; Lehmann V; Frasch CE; Solberg CO
    Infect Immun; 1984 Dec; 46(3):673-6. PubMed ID: 6437988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early development in healthy children of serum opsonins against nonpathogenic Neisseria meningitidis.
    Fredlund H; Selldén H; Danielsson D; Olcén P
    APMIS; 1992 May; 100(5):449-54. PubMed ID: 1586482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum opsonins to group B meningococci.
    Sjursen H; Bjerknes R; Halstensen A; Naess A; Frøholm LO; Rosenqvist E; Solberg CO
    Acta Pathol Microbiol Immunol Scand C; 1987 Dec; 95(6):283-9. PubMed ID: 3126623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reacting serum opsonins in patients with meningococcal disease.
    Guttormsen HK; Bjerknes R; Naess A; Lehmann V; Halstensen A; Sørnes S; Solberg CO
    Infect Immun; 1992 Jul; 60(7):2777-83. PubMed ID: 1612745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human opsonins induced during meningococcal disease recognize transferrin binding protein complexes.
    Lehmann AK; Gorringe AR; Reddin KM; West K; Smith I; Halstensen A
    Infect Immun; 1999 Dec; 67(12):6526-32. PubMed ID: 10569771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody and complement in the stimulation of neutrophil chemiluminescence by Neisseria meningitidis: studies in a patient with complete deficiency of C7.
    Edwards KM; Gewurz H; Sokalski SJ; Chan L; Lint TF
    J Infect Dis; 1982 Jan; 145(1):65-71. PubMed ID: 6798131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional assays for evaluation of serogroup B meningococcal structures as mediators of human opsonophagocytosis.
    Lehmann AK; Halstensen A; Holst J; Bassøe CF
    J Immunol Methods; 1997 Jan; 200(1-2):55-68. PubMed ID: 9005944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reacting serum opsonins to meningococci after vaccination.
    Guttormsen HK; Bjerknes R; Halstensen A; Naess A; Høiby EA; Solberg CO
    J Infect Dis; 1993 Jun; 167(6):1314-9. PubMed ID: 8501320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction in vitro between group B meningococci and rabbit polymorphonuclear leukocytes. Demonstration of type specific opsonins and bactericidins.
    Roberts RB
    J Exp Med; 1967 Nov; 126(5):795-818. PubMed ID: 4964859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonic activity of serum in the acute phase of meningitis.
    Kharazmi A; Eriksen HO; Willumsen L; Rønne-Rasmussen JO; Permin H; Faber V
    Acta Pathol Microbiol Immunol Scand C; 1986 Aug; 94(4):167-70. PubMed ID: 3788577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum opsonins to serogroup B meningococci after disease and vaccination.
    Halstensen A; Lehmann AK; Guttormsen HK; Vollset SE; Bjune G; Naess A
    NIPH Ann; 1991 Dec; 14(2):157-65; discussion 166-7. PubMed ID: 1812430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.
    Hemming VG; Hall RT; Rhodes PG; Shigeoka AO; Hill HR
    J Clin Invest; 1976 Dec; 58(6):1379-87. PubMed ID: 62761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man.
    Roberts RB
    J Exp Med; 1970 Mar; 131(3):499-513. PubMed ID: 4189835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Haemophilus influenzae type b opsonins by neutrophil chemiluminescence.
    Kaplan SL; Umstead CL; Mason EO; Anderson DC; Parke JC; Feigin RD
    J Clin Microbiol; 1981 Mar; 13(3):532-9. PubMed ID: 6972383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.